Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03960853
Other study ID # 2019ZSLYEC-184
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2019
Est. completion date December 31, 2021

Study information

Verified date June 2019
Source Sixth Affiliated Hospital, Sun Yat-sen University
Contact Dongxue Li
Phone 008615802037417
Email liguoqing2010@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In 1967, the term "respirator lung" was coined to describe the diffuse alveolar infiltrates and hyaline membranes that were found on postmortem examination of patients who had undergone mechanical ventilation.This mechanical ventilation can aggravate damaged lungs and damage normal lungs. In recent years, Various ventilation strategies have been used to minimize lung injury, including low tide volume, higher PEEPs, recruitment maneuvers and high-frequency oscillatory ventilation. which have been proved to reduce the occurrence of lung injury.

In 2012,Needham et al. proposed a kind of lung protective mechanical ventilation, and their study showed that limited volume and pressure ventilation could significantly improve the 2-year survival rate of patients with acute lung injury.Volume controlled ventilation is the most commonly used method in clinical surgery at present.Volume controlled ventilation(VCV) is a time-cycled, volume targeted ventilation mode, ensures adequate gas exchange. Nevertheless, during VCV, airway pressure is not controlled.Pressure controlled ventilation(PCV) can ensure airway pressure,however minute ventilation is not guaranteed.Pressure controlled ventilation-volume guarantee(PCV-VG) is an innovative mode of ventilation utilizes a decelerating flow and constant pressure. Ventilator parameters are automatically changed with each patient breath to offer the target VT without increasing airway pressures. So PCV-VG has the advantages of both VCV and PCV to preserve the target minute ventilation whilst producing a low incidence of barotrauma pressure-targeted ventilation.

Current studies on PCV-VG mainly focus on thoracic surgery, bariatric surgery and urological surgery, and the research indicators mainly focus on changes in airway pressure and intraoperative oxygenation index.The age of patients undergoing laparoscopic colorectal cancer resection is generally higher, the cardiopulmonary reserve function is decreased, and the influence of intraoperative pneumoperitoneum pressure and low head position increases the incidence of intraoperative and postoperative pulmonary complications.Whether PCV-VG can reduce the incidence of intraoperative lung injury and postoperative pulmonary complications in elderly patients undergoing laparoscopic colorectal cancer resection, and thereby improve postoperative recovery of these patients is still unclear.


Description:

One hundred patients undergoing elective laparoscopic colorectal cancer resection (age > 65 years old, body mass index(BMI)18-30 kg/m2, American society of anesthesiologists(ASA )grading Ⅰ - Ⅲ ) will be randomly assigned to volume control ventilation(VCV)group and pressure controlled ventilation-volume guarantee(PCV-VG)group.General anesthesia combined with epidural anesthesia will be used to both groups.

Ventilation settings in both groups are VT 8 mL/kg,inspiratory/expiratory (I/E) ratio 1:2,inspired oxygen concentration (FIO2) 0.5 with air,2.0 L/min of inspiratory fresh gas flow,positive end-expiratory pressure (PEEP) 0 millimeter of mercury (mmHg),respiratory rate (RR) was adjusted to maintain an end tidal CO2 pressure (ETCO2) of 35 -45 mmHg.

In operation dates will be collected at the following time points: preanesthesia, 1 hour after pneumoperitoneum,2 hours after pneumoperitoneum ,30 minutes after admission to post-anaesthesia care unit (PACU) .The dates collected or calculated are the following:1)peak airway pressure,plate airway pressure, mean inspiratory pressure, dynamic compliance, RR,Exhaled VT andETCO2,2) Arterial blood gas analysis: arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2),power of hydrogen(PH), and oxygen saturation (SaO2),3) Oxygenation index (OI) calculation; PaO2/FIO2, 4) Ratio of physiologic dead-space over tidal volume(Vd/VT) (expressed in %) was calculated with Bohr's formula ; Vd/VT = (PaCO2 - ETCO2)/PaCO2,5) Hemodynamics: heart rate, mean arterial pressure (MAP),and central venous pressure (CVP),6) lung injury markers :Interleukin 6(IL6),Interleukin 8(IL8),Clara cell protein 16(CC16),Solution advanced glycation end products receptor(SRAGE),tumor necrosis factor α(TNFα) .

Investigators will collect the following dates according to following-up after surgery: the incidence of postoperation pulmonary complications(PPC) based on PPC scale within seven days , incidence of pneumonia within seven days after surgery,incidence of atelectasis within seven days after surgery,length of hospital days after surgery, the incidence of postoperative unplanned admission to ICU, the incidence of operation complications within 7 days after surgery, the incidence of postoperative systematic complications within 7 days after surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

1. scheduled for Laparoscopic colorectal cancer resection

2. age >65 years

3. body mass index(BMI) 18-30kg / m2

4. ASA grading?-?

Exclusion Criteria:

1. history of lung surgery

2. severe restrictive or obstructive pulmonary disease (preoperative lung function test: forced vital capacity(FVC)< 50% predictive value of FVC,forced expiratory volume at one second(FEV1)< 50% predictive value of FEV1

3. Acute respiratory failure, pulmonary infection, ALI/ARDS, and acute stage of asthmaAcute respiratory failure, pulmonary infection, acute lung injury(ALI),acute respiratory distress syndrome(ARDS), and acute stage of asthma (bronchodilators were needed for treatment) were found within 1 month before surgery

4. Patients at risk of preoperative reflux aspiration

5. Preoperative positive pressure ventilation (as obstructive sleep apnea hypopnea syndrome patients) or long-term home oxygen therapy were performed

6. Serious heart, liver and kidney diseases: heart function class more than 3, severe arrhythmia (sinus bradycardia (ventricular rate < 60 times/min), atrial fibrillation, atrial flutter, atrioventricular block, frequent premature ventricular and polyphyly ventricular early, early to R on T, ventricular fibrillation and ventricular flutter), acute coronary syndrome, liver failure, kidney failure

7. Neuromuscular diseases affect respiratory function, such as Parkinson's disease, myasthenia gravis and cerebral infarction affect normal breathing

8. Mental illness, speech impairment, hearing impairment

9. Contraindications for spinal anesthesia puncture

10. Refuse to participate in this study or participate in other studies -

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
pressure-controlled ventilation-volume guaranteed
patients will be allocated to pressure-controlled ventilation-volume guaranteed in operation
volume controlled ventilation
patients will be allocated to pressure-controlled ventilation volume guaranteed in operation

Locations

Country Name City State
China Six Affiliated Hospital, Sun Yat-sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Sixth Affiliated Hospital, Sun Yat-sen University

Country where clinical trial is conducted

China, 

References & Publications (9)

Ball L, Dameri M, Pelosi P. Modes of mechanical ventilation for the operating room. Best Pract Res Clin Anaesthesiol. 2015 Sep;29(3):285-99. doi: 10.1016/j.bpa.2015.08.003. Epub 2015 Sep 2. Review. — View Citation

Choi EM, Na S, Choi SH, An J, Rha KH, Oh YJ. Comparison of volume-controlled and pressure-controlled ventilation in steep Trendelenburg position for robot-assisted laparoscopic radical prostatectomy. J Clin Anesth. 2011 May;23(3):183-8. doi: 10.1016/j.jclinane.2010.08.006. Epub 2011 Mar 4. — View Citation

Dion JM, McKee C, Tobias JD, Sohner P, Herz D, Teich S, Rice J, Barry ND, Michalsky M. Ventilation during laparoscopic-assisted bariatric surgery: volume-controlled, pressure-controlled or volume-guaranteed pressure-regulated modes. Int J Clin Exp Med. 2014 Aug 15;7(8):2242-7. eCollection 2014. — View Citation

Kalmar AF, Foubert L, Hendrickx JF, Mottrie A, Absalom A, Mortier EP, Struys MM. Influence of steep Trendelenburg position and CO(2) pneumoperitoneum on cardiovascular, cerebrovascular, and respiratory homeostasis during robotic prostatectomy. Br J Anaesth. 2010 Apr;104(4):433-9. doi: 10.1093/bja/aeq018. Epub 2010 Feb 18. — View Citation

Mahmoud K, Ammar A, Kasemy Z. Comparison Between Pressure-Regulated Volume-Controlled and Volume-Controlled Ventilation on Oxygenation Parameters, Airway Pressures, and Immune Modulation During Thoracic Surgery. J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1760-1766. doi: 10.1053/j.jvca.2017.03.026. Epub 2017 Mar 22. — View Citation

Needham DM, Colantuoni E, Mendez-Tellez PA, Dinglas VD, Sevransky JE, Dennison Himmelfarb CR, Desai SV, Shanholtz C, Brower RG, Pronovost PJ. Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study. BMJ. 2012 Apr 5;344:e2124. doi: 10.1136/bmj.e2124. — View Citation

Respirator lung syndrome. Minn Med. 1967 Nov;50(11):1693-705. — View Citation

Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013 Nov 28;369(22):2126-36. doi: 10.1056/NEJMra1208707. Review. Erratum in: N Engl J Med. 2014 Apr 24;370(17):1668-9. — View Citation

Tran D, Rajwani K, Berlin DA. Pulmonary effects of aging. Curr Opin Anaesthesiol. 2018 Feb;31(1):19-23. doi: 10.1097/ACO.0000000000000546. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary occurrence rate of Oxygenation index=300mmHg Oxygenation index(OI)=PaO2/FiO2 10minutes before anesthesia,1 hour after pneumoperitoneum,2 hour after pneumoperitoneum,30 minutes after after extubation
Secondary Occurrence rate of pulmonary complications Pulmonary complications were assessed using the Postoperation Pulmonary complication ( PPC) scale,The scale is divided into four grades, with 0 indicating no pulmonary complications and 1 to 4 indicating increasingly severe pulmonary complications. Day 0 to 7 after surgery
Secondary incidence of pneumonia record the occurrence rate of pneumonia after surgery Day 0 to 7 after surgery
Secondary incidence of pulmonary atelectasis record the occurrence rate of pulmonary atelectasis after surgery Day 0 to 7 after surgery
Secondary peak airway pressure Peak airway Pressure(Ppeak, cm H2O) through mechanical ventilation,average of 3 hours
Secondary Plateau airway pressure Plateau airway pressure(Pplat, cm H2O) through mechanical ventilation,average of 3 hours
Secondary Static lung compliance Static lung compliance (Csta, ml/cm H2O) = Vt/ (Pplat-PEEP) through mechanical ventilation,average of 3 hours
Secondary Dynamic lung compliance Dynamic lung compliance (Cdyn , ml/cm H2O)= Vt/ (Ppeak-PEEP) through mechanical ventilation,average of 3 hours
Secondary Arterial partial pressure of oxygen Arterial partial pressure of oxygen (PaO2, mmHg) 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation
Secondary assessing change of Alveolar-arterial oxygen tension difference Alveolar-arterial oxygen tension difference (mmHg) 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation
Secondary assessing change of Respiratory index Fraction of inspired oxygen (FiO2); Respiratory index (RI) =Ratio of alveolar-arterial oxygen tension difference to FiO2 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation
Secondary assessing change of Alveolar dead space fraction Arterial carbon dioxide partial pressure (PaCO2); partial pressure of carbon dioxide in endexpiratory gas (PetCO2); Alveolar dead space fraction (Vd/Vt)=(PaCO2-PetCO2)/ PaCO2; 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum,30 minutes after extubation
Secondary assessing change of lactic acid lactate ( LAC), mmol/L 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation
Secondary assessing change of Advanced glycation end products receptor Advanced glycation end products receptor (RAGE, pg/ml) 10 minutes before anesthesia,30 minutes after extubation
Secondary assessing change of Tumor Necrosis Factor alpha Tumor Necrosis Factor alpha (TNF-a, pg/ml) 10 minutes before anesthesia,30 minutes after extubation
Secondary assessing change of Interleukin 6 Interleukin 6 (IL-6, pg/ml) 10 minutes before anesthesia,30 minutes after extubation
Secondary assessing change of Interleukin 8 Interleukin 8 (IL-8, pg/ml) 10 minutes before anesthesia,30 minutes after extubation
Secondary assessing change of Clara cell protein 16, Clara cell protein 16, 10 minutes before anesthesia,30 minutes after extubation
Secondary The occurrence rate of hypoxemia in PACU The occurrence rate of hypoxemia (SPO2<90% or PaO2<60 mmHg) in PACU 30 minutes after extubation
Secondary Occurrence rate of operation complications abdominal abscess, anastomotic fistula, bleeding and the incidence of reoperation within 7 days within 7 days after operation
Secondary Occurrence rate of Systemic complications Systemic complications including sepsis and septic shock within 7 days after surgery
Secondary Antibiotic dosages record the Antibiotic dosages within 7 days after surgery within 7 days after surgery
Secondary incidence of Unplanned admission to ICU Unplanned admission to ICU within 30 days after surgery within 30 days after surgery
Secondary Length of ICU stay within 30 days after surgery Length of ICU stay within 30 days after surgery within 30 days after surgery
Secondary Length of hospital stay within 30 days after surgery Length of hospital stay within 30 days after surgery within 30 days after surgery
Secondary Death from any cause Death from any cause 30 days after surgery within 30 days after surgery
Secondary The occurrence rate of hypoxemia after surgery The occurrence rate of hypoxemia (SPO2<90% or PaO2<60 mmHg) after surgery within 7 days after surgery
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05054270 - Efficacy of Lung Ultrasound in Monitoring Fluid Resuscitation in Chest Trauma Patients
Not yet recruiting NCT04470297 - Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19 Phase 2
Not yet recruiting NCT01184313 - Acute Lung Injury After Aortic Valve Surgery N/A
Not yet recruiting NCT06296173 - Open Lung Protective Extubation Following General Anesthesia N/A
Not yet recruiting NCT06446544 - Functional Residual Capacity and Alveolar Recruitment in Single-lung Ventilation: a Randomized Study N/A
Not yet recruiting NCT03661502 - Effect of Variable Volume Ventilation on Lung Compliance N/A
Recruiting NCT04296071 - Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
Completed NCT04645316 - The Effect of Sevoflurane and Desflurane on Clara Cell Protein on the Lung N/A
Recruiting NCT02299921 - Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
Recruiting NCT05559970 - Inhalational Sedation and Mechanical Power N/A
Completed NCT03581006 - Food Intake REstriction for Health OUtcome Support and Education (FIREHOUSE) Trial
Recruiting NCT05228717 - Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19
Recruiting NCT04372953 - Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial). N/A
Not yet recruiting NCT05363085 - The Cerebral-Respiratory Interaction in Controlled Mechanically Ventilated Neurosurgical Patients. (The CeRes-CMV Study)
Recruiting NCT02444858 - Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury Phase 1/Phase 2
Completed NCT03924206 - Hazardous Surgical Smoke: Risk Assessment and Evaluation of a New Smoke Extractor System in the Surgical Unit
Recruiting NCT06416709 - Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases Phase 1/Phase 2
Withdrawn NCT01939067 - Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP Phase 1
Recruiting NCT05401474 - Individualization Flow in Patients Treated With High Flow Nasal Therapy (iFLOW) N/A
Completed NCT03437499 - Adrenomedullin Changes After Sustained Inflation or Positive Pressure Ventilation at Birth N/A